CytomX Therapeutics: Still Some Ways To Go
Source: SeekingAlpha
2026-03-17 14:07:58 ET
Today, I am putting CytomX Therapeutics, Inc. ( CTMX ) in the spotlight. The stock jumped by nearly 45% on Monday after posting Q4 results before the bell. Management also launched a large secondary offering to raise additional funding after the bell on Monday. A post-earnings/pipeline update assessment follows below....
Read the full article on Seeking Alpha
For further details see:
CytomX Therapeutics: Still Some Ways To Go
CytomX Therapeutics Inc.
NASDAQ: CTMX
CTMX Trading
-5.93% G/L:
$4.365 Last:
1,213,368 Volume:
$4.49 Open:
CTMX Latest News
March 17, 2026 10:46:40 pm
CytomX Therapeutics Announces Pricing of $250 Million Offering of Common Stock and Pre-Funded Warrants
March 16, 2026 06:56:37 pm
Stock Market Today, March 16: CytomX Therapeutics Surges After Positive Phase 1 Colorectal Cancer Data
March 16, 2026 04:04:55 pm
CytomX Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
CTMX Stock Data
$945,449,504
141,817,426
0.97%
31
N/A
Biotechnology & Life Sciences
Healthcare
US
South San Francisco
